Envoy Medical (COCH) Cash from Operations (2021 - 2026)

Envoy Medical has disclosed Cash from Operations across 6 years of filings, most recently posting -$5.5 million for Q2 2026.

• In Q2 2026, Cash from Operations fell 22.33% year-over-year to -$5.5 million; the TTM figure through Jun 2026 stood at -$21.5 million (down 35.44% YoY), while the FY2025 annual figure was -$18.2 million, down 1.4% from the prior year.
• Cash from Operations came in at -$5.5 million for Q2 2026 at Envoy Medical, up from -$6.1 million in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of $1.1 million in Q3 2023 to a low of -$11.1 million in Q4 2023.
• Average Cash from Operations over 5 years is -$4.1 million, with a median of -$4.4 million recorded in 2025.
• The largest YoY upside for Cash from Operations was 120.92% in 2023 against a maximum downside of 908.1% in 2023.
• Over 5 years, Cash from Operations stood at -$2.4 million in 2022, then plunged by 368.47% to -$11.1 million in 2023, then surged by 54.32% to -$5.1 million in 2024, then slipped by 11.67% to -$5.7 million in 2025, then advanced by 4.03% to -$5.5 million in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were -$5.5 million in Q2 2026, -$6.1 million in Q1 2026, and -$5.7 million in Q4 2025.